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INTRODUCTION
Chairman’s comments
This symposium is entitled ‘Time to re-evaluate
antimicrobial agents in an era of increasing resis-
tance’ since resistance to many existing antibacter-
ial agents in diverse species of bacteria poses a
signiﬁcant threat and is of concern world-wide.
There are many unanswered questions regarding
the development of resistance, its importance in
the clinic and its management. How does resis-
tance or susceptibility of a bacterium to an anti-
microbial in the laboratory relate to clinical
practice? How widespread is resistance indifferent
countries? Can prescribers limit the increase in
resistance while still providing the best standard
of care for their patients? Is resistance linked to the
type of antibacterial, its use, or the route by which
it is administered?
We have presentations by three eminent people
in the ﬁeld who address various aspects of this
difﬁcult but highly topical subject. The ﬁrst pre-
sentation on epidemiology is from Professor
Gian Carlo Schito of the Istituto di Microbiologia,
Universita´ di Genova, Italy. Professor Schito will
considerwhether resistance to antimicrobials is also
subject to globalization. Professor Donald E. Low
fromtheDepartmentofMicrobiology,Universityof
Toronto, Canada discusses the implications of this
resistance for the clinical laboratory and how it
impinges on the methods used for testing the sus-
ceptibility of a bacterial isolate to an antimicrobial.
ProfessorRogerG.Finch fromtheCityHospital and
UniversityofNottingham,UKlooksat thechallenge
to the clinician that is posed by resistance; is the
information on resistance patterns readily available
to them and are they aware of it?
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